Established in 2014, the company has developed decision support tools for diabetes management, including the Advisor Pro software, which uses artificial intelligence to analyze patient data and advise on optimal treatment plans. With FDA clearance for its decision support system using data from CGM/SMBG and insulin pumps, DreaMed Diabetes offers a clinically proven system for insulin titration in type 1 diabetes patients. By allowing frequent titration changes and online monitoring, the system helps lower A1C levels and reduce the risk of complications, enabling healthcare professionals to provide patient-centered care and improve treatment outcomes while lowering overall costs.